Alnylam Pharmaceuticals, Inc.
2020 Q3 - 2025 Q4 (14 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/11/2026 | 10,248 | 0.1% | 25,771 | 12/31/2025 |
| 2025 Q3 | 11/6/2025 | 12,378 | 0.2% | 27,145 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 8,493 | 0.1% | 26,046 | 6/30/2025 |
| 2025 Q1 | 4/24/2025 | 16,921 | 0.2% | 62,665 | 3/31/2025 |
| 2024 Q4 | 2/4/2025 | 14,746 | 0.2% | 62,665 | 12/31/2024 |
| 2024 Q3 | 11/4/2024 | 10,277 | 0.1% | 37,367 | 9/30/2024 |
| 2024 Q2 | 8/5/2024 | 8,960 | 0.1% | 36,872 | 6/30/2024 |
| 2024 Q1 | 5/7/2024 | 3,942 | 0.1% | 26,375 | 3/31/2024 |
| 2023 Q3 | 11/6/2023 | 2,771 | 0.1% | 15,644 | 9/30/2023 |
| 2023 Q1 | 5/5/2023 | 477 | 0.0% | 2,381 | 3/31/2023 |
| 2022 Q2 | 8/5/2022 | 472 | 0.0% | 3,239 | 6/30/2022 |
| 2021 Q1 | 4/27/2021 | 592 | 0.0% | 4,194 | 3/31/2021 |
| 2020 Q4 | 2/9/2021 | 545 | 0.0% | 4,194 | 12/31/2020 |
| 2020 Q3 | 11/3/2020 | 335 | 0.0% | 2,303 | 9/30/2020 |